✦ LIBER ✦

Efficacy of intravenous immunoglobulins in patients with advanced HIV-1 infection. A randomized clinical study

✍ Scribed by U. Brunkhorst; M. Stürner; H. Willers; H. Deicher; I. Schedel

Publisher: Springer-Verlag
Year: 1990
Tongue: English
Weight: 688 KB
Volume: 18
Category: Article
ISSN: 0300-8126
DOI: 10.1007/bf01641421

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of cervicovaginal humoral imm

Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC Al and A2 category) patients with HIV-1 and HIV-2 infection

✍ Laurent Bélec; Carol Tévi-Bénissan; Thiérry Dupré; Ali Si Mohamed; Thiérry Prazu 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 833 KB

Combined efficacy of fosfomycin and sulb

Combined efficacy of fosfomycin and sulbactam/cefoperazone in opportunistic infections in patients with hematologic disorders—A randomized comparative study of antibiotic efficacy based on the order of sequential administration

✍ Hirofumi Hasegawa; Atsushi Horiuchi; Akira Hiraoka; Tohru Masaoka; Minoru Okuma; 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 672 KB

Immunomodulation in patients receiving i

Immunomodulation in patients receiving intravenous Bryostatin 1 in a phase I clinical study: comparison with effects of Bryostatin 1 on lymphocyte function in vitro

✍ Christof Scheid; Joseph Prendiville; Gordon Jayson; Derek Crowther; Brian Fox; G 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 798 KB

Presence of proliferating (MiB-1-positiv

Presence of proliferating (MiB-1-positive) cells in cervical smears of women infected with HIV is associated with clinical outcome: A study of Brazilian women

✍ Mathilde E. Boon; Gerrita van der Veen; Yvonne Barlow; Marcia Silveira Graudenz; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

A multicenter, randomized, double-blind

A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: Results of a phase III clinical trial

✍ Daniel L. Rubin; Terry S. Desser; Richard Semelka; Jeffrey Brown; Hanh V. Nghiem 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views

Golimumab, a new human anti–tumor necros

Golimumab, a new human anti–tumor necrosis factor α antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight–week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study

✍ Joel Kremer; Christopher Ritchlin; Alan Mendelsohn; Daniel Baker; Lilianne Kim; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB 👁 1 views